Dark
Streaming/Mobile
Old Site
Home
Products
Help
Contact Us
Your Account
System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
17:12:46 EDT Thu 28 Mar 2024
Quotes
Streaming/Mobile
Quick Quotes (x20)
Symbol Search
Company Search
Market Depth
US Options
Montreal Options
Foreign Exchange
Download Close Prices
Short History
Quotes Help
Charts
12 Month Chart
Advanced Chart
Live Intraday Chart
Live Historical Chart
Live Java Intraday Chart
Live Java Historical Chart
Charts Help
News
News Search
SEDAR Search
SEDAR Alerts
News Help
Indexes
Major Indexes
US incl Dow Jones
NASDAQ
S&P CME
PBOT - Phil Ex
TSX - Toronto
TSX-V - TSX Venture
Indexes Help
Portfolio
View Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Value Portfolio
All Portfolios
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Edit Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Chart Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Live Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
View Portfolio News
Daily Summary
Portfolio Help
Analytics
Exchange Statistics
Most Active
Live Most Active
Block Trades
Broker Trades
Halted Stocks
Dividends
Participants
Companies
Trade Workstation
Company Picker
Short Positions
Broker Codes
Analytics Help
Mutual Funds
Mutual Fund Search
Targeted Holder Search
SEDAR Fund Search
Mutual Fund Help
Enter Symbol
or Name
USA
CA
Quote
Chart
News
Closes
Depth
Forgot password?
Trouble logging in?
Login to Stockwatch
News for U:MNOV from 2023-03-29 to 2024-03-28 - 18 items
News Releases
In The News
Other
CA
US
Date
Sym
Price
Type
Headline
2024-03-26 19:00
U
U:MNOV
News Release
200
MediciNova Receives a Notice of Allowance for a New Patent Covering MN-166 (ibudilast) for the Treatment of Macular Injury in Japan
2024-03-20 19:00
U
U:MNOV
News Release
200
MediciNova Announces Two Abstracts regarding MN-001 (tipelukast) and MN-002 Accepted for Presentation at the 92nd EAS 2024 Congress, the Annual Meeting of the European Atherosclerosis Society
2024-03-12 06:30
U
U:MNOV
News Release
200
MediciNova Announces New Data and Results of MN-166 (ibudilast) in Chlorine Gas-induced Acute Lung Injury Presented at the 63rd Annual Meeting of the Society of Toxicology
2024-01-17 06:00
U
U:MNOV
News Release
200
MediciNova Receives a Notice of Grant for a New Patent Covering MN-166 (ibudilast) for the Treatment of Macular Injury in China
2023-12-21 18:00
U
U:MNOV
News Release
200
MediciNova Announces Abstract Regarding MN-166 (ibudilast) in Chlorine Gas-induced Lung Injury Accepted for Presentation at the 63rd Annual Meeting of the Society of Toxicology
2023-12-06 18:00
U
U:MNOV
News Release
200
MediciNova Receives a Notice of Decision to Grant for ‚ a New Patent Covering MN-166 (ibudilast) for the Treatment of Progressive MS in Europe
2023-11-19 18:00
U
U:MNOV
News Release
200
MediciNova Announces New Data and Results of a Phase 2 Clinical Trial of MN-166 (ibudilast) in Glioblastoma Presented at the 28th Annual Meeting of the Society for Neuro-Oncology
2023-10-27 01:00
U
U:MNOV
News Release
200
MediciNova ¢ € ™s Collaborator Initiates Clinical Development of a Gene Therapy Product for the Treatment of Phenylketonuria
2023-10-10 19:00
U
U:MNOV
News Release
200
MediciNova Receives a Notice of Allowance for ‚ a New Patent Covering the Combination of MN-166 (ibudilast) and Riluzole for the Treatment of Amyotrophic Lateral Sclerosis (ALS) in Canada
2023-10-04 19:00
U
U:MNOV
News Release
200
MediciNova Receives Gene Therapy Milestone Payment
2023-09-27 19:00
U
U:MNOV
News Release
200
MediciNova Announces Results of Studies under BARDA Contract to Develop MN 166 (ibudilast) as a Medical Countermeasure Against Chlorine Gas-induced Lung Injury
2023-08-17 19:00
U
U:MNOV
News Release
200
MediciNova Announces Abstract Regarding MN-166 (ibudilast) in Glioblastoma Accepted for Presentation at the Annual Meeting of the Society for Neuro-Oncology
2023-08-16 19:00
U
U:MNOV
News Release
200
MediciNova Receives a Notice of Intention to Grant for ‚ a New Patent Covering MN-166 (ibudilast) for the Treatment of Macular Injury in Europe
2023-08-15 19:00
U
U:MNOV
News Release
200
MediciNova Receives a New Patent Covering MN-001 for the Treatment of Scleroderma and Systemic Sclerosis in Europe
2023-08-14 19:00
U
U:MNOV
News Release
200
MediciNova Receives a Notice of Intention to Grant for a New Patent Covering MN-001 and MN-002 for the Treatment of Advanced NASH in Europe
2023-06-29 06:00
U
U:MNOV
News Release
200
MediciNova Announces Presentation of Results from the Phase 2b Trial of MN-166 (ibudilast) in Alcohol Use Disorder at the 46th Annual Research Society on Alcohol (RSA) Scientific Meeting
2023-05-14 19:00
U
U:MNOV
News Release
200
MediciNova Receives a Notice of Intention to Grant for ‚ a New Patent Covering MN-166 (ibudilast) for Patients with Microorganism Infection in Europe
2023-04-30 19:00
U
U:MNOV
News Release
200
MediciNova Receives a Notice of Allowance for a New Patent Covering MN-001 for the Treatment of Advanced NASH in Canada